XML 78 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Mezzanine and Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2017
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The stock options under the Exclusivity Amendment Agreement were accounted for at fair value, as determined using the Black-Scholes option pricing model and the following assumptions:
  
Year ended December 31,
 
2017
 
2016
 
 
 
 
 
 
 
 
 
Expected term
 
 
0.93 - 1.75 years
 
 
2.75 years
 
Expected volatility
 
 
38.10% - 41.60
%
 
53.01
%
Risk-free interest rate
 
 
1.64% - 1.86
%
 
1.47
%
Market value of common stock
 
 
$0.52 - $0.76
 
 
$0.52 - $0.76
 
Annual dividend yield
 
 
2.23% - 3.53
%
 
2.51% - 3.53
%
Forfeiture rate
 
 
0% - 6.8
%
 
8
%
Warrants Outstanding
Warrants consisted of the following:
 
 
 
Shares
 
Weighted 
Average 
Exercise Price
 
Weighted
Average 
Remaining 
Contractual 
Term 
(Years)
 
Aggregate 
Intrinsic 
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants outstanding at January 1, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants assumed in the Merger
 
 
1,898,541
 
$
9.06
 
 
2.69
 
$
14.94
 
Warrants granted
 
 
1,750,000
 
 
10.49
 
 
5.00
 
 
13.51
 
Warrants exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
Warrants forfeited
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Warrants outstanding at December 31, 2017
 
 
3,648,541
 
$
9.75
 
 
3.74
 
$
14.25
 
 
 
 
Weighted-Average
Per Share
Intrinsic Value
 
Number of
Warrants
 
 
 
 
 
 
 
 
 
Outstanding at December 31, 2016
 
$
-
 
 
-
 
Warrants assumed in the Merger
 
 
0.94
 
 
1,898,541
 
Granted
 
 
-
 
 
1,750,000
 
Exercised
 
 
-
 
 
-
 
Cancelled
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
Outstanding at December 31, 2017
 
$
14.25
 
 
3,648,541
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted
 
 
 
 
 
 
 
Weighted
 
 
 
 
Average
 
 
 
 
 
 
 
Average
 
 
 
 
Exercise Price
 
Exercise Price Per
 
Warrants
 
Remaining
 
Warrants
 
Per
 
Share
 
Outstanding
 
Contractual Life
 
Exercisable
 
Share
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
4.00 - 4.50
 
 
116,875
 
 
0.24
 
 
116,875
 
$
4.41
 
 
9.00 – 10.00
 
 
2,681,666
 
 
3.51
 
 
2,681,666
 
 
9.58
 
 
11.00
 
 
850,000
 
 
4.94
 
 
850,000
 
 
11.00
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
4.50 –10.00
 
 
3,648,541
 
 
3.74
 
 
3,648,541
 
$
9.75
 
Contracted physicians and other services [Member]  
Stock Option Transactions Under Stock Option Plans
Share-based compensation expense related to common stock option awards granted in connection with the Exclusivity Amendment Agreement recognized over their respective vesting periods is as follows:
 
Year ended December 31,
 
2017
 
2016
 
 
 
 
 
 
 
 
 
Contracted physicians and other services
 
$
2,113,116
 
$
1,512,740
 
Exclusivity Amendment Agreement, NMM [Member]  
Stock Option Transactions Under Stock Option Plans
The Company’s stock option activity for options grants under the Exclusivity Amendment Agreement for NMM is summarized below:
 
 
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at January 1, 2016
 
 
139,016
 
$
2.44
 
 
3.75
 
$
473,363
 
Options granted
 
 
-
 
 
-
 
 
-
 
 
-
 
Options exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
Options forfeited
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at December 31, 2016
 
 
139,016
 
$
2.44
 
 
2.75
 
$
717,155
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at December 31, 2016
 
 
139,016
 
$
2.44
 
 
2.75
 
$
717,155
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at January 1, 2017
 
 
139,016
 
$
2.44
 
 
2.75
 
$
717,155
 
Options granted
 
 
 
 
 
 
 
 
 
 
 
 
 
Options exercised
 
 
(102,199)
 
 
2.44
 
 
-
 
 
527,223
 
Options forfeited
 
 
(36,817)
 
 
2.44
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at December 31, 2017
 
 
-
 
$
-
 
 
-
 
$
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at December 31, 2017
 
 
-
 
$
-
 
 
-
 
$
-
 
Exclusivity Amendment Agreement, APC [Member]  
Stock Option Transactions Under Stock Option Plans
The Company’s stock option activity for options grants under the Exclusivity Amendment Agreement for APC is summarized below:
  
 
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at January 1, 2016
 
 
1,910,400
 
$
0.167
 
 
3.75
 
$
960,931
 
Options granted
 
 
-
 
 
-
 
 
-
 
 
-
 
Options exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
Options forfeited
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at December 31, 2016
 
 
1,910,400
 
$
0.167
 
 
2.75
 
$
1,138,598
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at December 31, 2016
 
 
1,910,400
 
$
0.167
 
 
2.75
 
$
1,138,598
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at January 1, 2017
 
 
1,910,400
 
$
0.167
 
 
2.75
 
$
1,138,598
 
Options granted
 
 
-
 
 
-
 
 
-
 
 
-
 
Options exercised
 
 
(1,056,600)
 
 
0.167
 
 
-
 
 
629,734
 
Options forfeited
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at December 31, 2017
 
 
853,800
 
$
0.167
 
 
1.75
 
$
508,864
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at December 31, 2017
 
 
853,800
 
$
0.167
 
 
1.75
 
$
508,864
 
Employee Stock Option [Member]  
Stock Option Transactions Under Stock Option Plans
The activity of stock options under the 2010, 2013 and 2015 Plans are as follows:
 
 
 
Shares
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at January 1, 2017
 
 
-
 
$
-
 
 
-
 
$
-
 
Options assumed in the Merger (see Note 3)
 
 
1,141,040
 
 
3.95
 
 
5.85
 
 
5.81
 
Options granted
 
 
-
 
 
-
 
 
-
 
 
-
 
Options exercised
 
 
-
 
 
-
 
 
-
 
 
-
 
Options forfeited
 
 
-
 
 
-
 
 
-
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options outstanding at December 31, 2017
 
 
1,141,040
 
$
3.95
 
 
5.79
 
$
19.81
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Options exercisable at December 31, 2017
 
 
1,141,040
 
$
3.95
 
 
5.79
 
$
19.81